Sourcing Lidocaine from Japan: Options for International Healthcare Buyers

Lidocaine Supply and International Procurement

Lidocaine (lidocaine hydrochloride) is one of the most widely used local anaesthetics in clinical practice. It is used across dental surgery, minor surgical procedures, regional anaesthesia, and cardiac arrhythmia management. Despite its status as an essential medicine, supply disruptions—driven by manufacturing issues, raw material shortages, or logistics constraints—periodically affect markets around the world.

Japan produces a wide range of lidocaine formulations under robust GMP-compliant manufacturing conditions, making Japanese-origin lidocaine a reliable sourcing option for international healthcare buyers when local supply is constrained or alternatives are needed.

Lidocaine Formulations Available in Japan

Japan’s approved pharmaceutical product base includes multiple lidocaine formulations across different clinical applications:

• Lidocaine hydrochloride injection: Available in multiple concentrations (1% and 2%), with and without epinephrine (adrenaline), for dental and surgical local anaesthesia
• Lidocaine viscous solution: For oral mucosal anaesthesia and topical application
• Lidocaine topical cream and ointment: For surface anaesthesia prior to venepuncture or minor procedures
• Lidocaine for intravenous infusion: For cardiac arrhythmia management in hospital settings
• Xylocaine (AstraZeneca Japan): The reference brand, widely distributed throughout Japan’s hospital and dental sectors

These formulations are searchable in the J-Lex database (db.tasakipharma.com) by active ingredient name or brand name.

Who Procures Japanese Lidocaine Internationally?

International procurement of Japanese lidocaine formulations is most common in the following situations:

• Supply shortage response: When domestic or regional supply of lidocaine becomes constrained, procurement teams seek alternative GMP-certified sources. Japan’s manufacturing base and established export infrastructure make it a practical alternative source.
• Specific formulation requirements: Certain lidocaine formulations—particularly specific concentrations or epinephrine combinations—may not be available in all markets. Japanese-origin versions of these formulations are accessible through pharmaceutical importation frameworks.
• Quality-assured supply diversification: Hospitals and dental chains seeking to reduce single-source supply risk may add Japanese-origin lidocaine to their approved supplier list.

Regulatory Considerations for Importing Lidocaine from Japan

Lidocaine is a widely licensed medicine in most markets, which means importation is typically subject to the standard unlicensed or parallel import framework rather than the rare disease or named patient pathway. Key considerations include:

• In the UK, importing Japanese lidocaine formulations not holding a UK Marketing Authorisation requires the importer to hold a WDA(H) with importation scope and to notify MHRA under the Specials framework.
• In Australia, unregistered lidocaine formulations may be accessed under the TGA Special Access Scheme.
• In Singapore, importation of formulations not registered on the SRTG requires HSA Special Access Route authorisation.
• In markets where lidocaine is a controlled or restricted substance, additional licensing may apply. Confirm local requirements before initiating procurement.

Documentation Available from Japanese Exporters

• Certificate of Origin (CoO) confirming Japanese manufacture
• Certificate of Analysis (CoA) with batch-level quality data
• Package insert / Patient Information Leaflet (Japanese language)
• GDP compliance documentation
• Manufacturer GMP certificate (PIC/S-compliant)

Finding Lidocaine Products: J-Lex Database

J-Lex (db.tasakipharma.com) lists Japan-approved lidocaine formulations with product details, manufacturer information, and packaging specifications. Search for “lidocaine” or “Xylocaine” to view available options and submit an enquiry directly.

How TASAKI PHARMA Supports Lidocaine Procurement

TASAKI PHARMA is a Taiwan-based pharmaceutical trading company with GDP and PIC/S GMP-compliant operations, experienced in supplying Japanese local anaesthetic products to dental and medical institutions internationally.

• Lidocaine hydrochloride injection, viscous, and topical formulations available via J-Lex
• CoO, CoA, and product documentation upon request
• GDP-compliant logistics with temperature monitoring
• Ex Works pricing in USD, EUR, or JPY

For product availability and pricing enquiries, visit tasakipharma.com or search J-Lex at db.tasakipharma.com.